Connect with us

Technology

Cytovale Recognized as One of Modern Healthcare’s 2024 Best in Business

Published

on

Company’s IntelliSep® rapid sepsis detection solution recognized for helping hospitals save lives and money while delivering patient-centered care

SAN FRANCISCO, Dec. 9, 2024 /PRNewswire/ — Cytovale®, a commercial-stage medical diagnostics company focused on advancing early detection technologies to diagnose fast-moving and immune-mediated diseases, today announced that it was recognized by Modern Healthcare as one of the Best in Business of 2024 in the laboratory medicine and medical technology categories for its IntelliSep® rapid sepsis detection solution.

This program celebrates companies that drive innovation, efficiency and excellence across the healthcare industry. By acknowledging the leading innovators within the industry, Modern Healthcare aims to highlight the pivotal role these organizations play in enhancing the overall healthcare ecosystem.

“We are honored to recognize the inaugural recipients of Modern Healthcare’s Best in Business Award,” said Dan Peres, president of Modern Healthcare. “Their unwavering commitment to innovation, exceptional outcomes, and delivering real impact in the healthcare industry exemplifies the very essence of excellence. This achievement underscores their dedication to advancing healthcare solutions and setting new standards for quality and efficiency. Congratulations to these outstanding organizations for their remarkable contributions and well-deserved recognition.”

IntelliSep is the first and only U.S. Food and Drug Administration (FDA)-cleared cellular host diagnostic indicated for use in the emergency department, where over 80% of sepsis cases present. The technology was first implemented at hospitals within the Franciscan Missionaries of Our Lady Health System (FMOLHS) across Louisiana and Mississippi. Taking only about eight minutes using a standard blood draw, IntelliSep provides clinicians a first-ever look into the biology that causes sepsis, enabling care teams to quickly and confidently identify the proper diagnosis and deliver appropriate care. Through use of the technology, the hospital has reported that the overall risk-adjusted mortality index was reduced by 30% for sepsis patients and patients at risk for sepsis were treated 60 to 70 minutes faster. Patients who were tested with IntelliSep and subsequently admitted spent 1.28 fewer days in the hospital, and the hospital realized an average savings of $1,429 per patient tested.

“Sepsis is more deadly than heart attack and stroke combined. In fact it’s the deadliest, costliest and arguably most complex condition facing hospitals today,” said Cytovale Co-founder and CEO Ajay Shah. “Our IntelliSep technology gives providers a fast, accurate way to detect or rule-out sepsis. Over the last year, we’ve demonstrated the clinical, financial and operational impact it’s making in hospital emergency departments. We’re honored to be recognized for our efforts and look forward to partnering with hospitals and health systems to improve patient care as we continue to expand across the country.”

Earlier this year Cytovale won the Digital Health Hub Foundation award for the Biggest Healthcare Savings Story and was named to Inc.’s 2024 Best in Business List.

About Cytovale
Cytovale is committed to improving patient care by pioneering early detection technologies that assess immune activation to accelerate the time it takes to get from triage to life-saving therapies. Cytovale’s U.S. Food and Drug Administration-cleared rapid sepsis diagnostic, IntelliSep®, leverages machine learning and advanced microfluidics to provide Emergency Department clinicians with an objective and highly sensitive early detection tool for sepsis. IntelliSep measures the dysregulated immune system response to infection that would indicate sepsis and generates results in about eight minutes using a standard blood draw. Cytovale is based in San Francisco and venture-backed by Norwest Venture Partners, Sands Capital and Global Health Investment Corporation (GHIC). For more information, visit www.cytovale.com and follow Cytovale on LinkedIn and X.

About Modern Healthcare
Modern Healthcare is the most trusted business news and information brand in the healthcare industry. Modern Healthcare empowers healthcare leaders and influencers to make timely and informed business decisions. To learn more or subscribe, go to www.modernhealthcare.com/subscriptions.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/cytovale-recognized-as-one-of-modern-healthcares-2024-best-in-business-302325914.html

SOURCE Cytovale

Continue Reading

Technology

Chelsea FC announces multi-year sleeve partnership with Sokin, the business payments and FX platform

Published

on

By

Chelsea FC name fast-growing fintech platform as Principal Partner

LONDON, Oct. 23, 2026 /PRNewswire/ — Chelsea Football Club has today announced a multi-year partnership with Sokin, the embedded finance and payments company used by businesses worldwide. Sokin will be named a Principal Partner and Official Business Payments and FX Partner of Chelsea FC and Chelsea FC Women.

As a Principal Partner, Sokin will be represented on the sleeves of the Chelsea FC men’s, women’s and academy home, away, and third kits from the 2026/27 season.

The partnership brings together two ambitious London-headquartered organisations with worldwide reach – a club with millions of fans across the world and a fintech platform through which businesses move more than $11 billion a year. A club of Chelsea’s scale works in many currencies every day, with partners, competitions and supporters around the world, and needs a financial partner built to handle that.

Sokin gives finance teams business payments, multi-currency accounts, foreign exchange, checkout and treasury in one place, so they spend less time juggling banks and providers and keep more of what they move.

As Official Business Payments and FX Partner, Sokin will simplify how Chelsea FC sends, receives and manages money in the currencies the club operates in.

The Sokin logo will feature on the sleeve of the Chelsea shirt for the first time [when the men’s team host Tottenham Hotspur at Stamford Bridge on Saturday 24th October.]

Jason Gannon, President at Chelsea FC said:

“At Chelsea, we seek to partner with organisations that share our ambition and innovative mindset. Sokin’s expertise in business payments, and their focus on making both simpler for the businesses they serve, makes them a natural fit for the Club. We are pleased to welcome Sokin to the Chelsea family and look forward to working together in the years ahead.”

Vroon Modgill, CEO and founder at Sokin said:

“Chelsea plays on the biggest stage in world football, and its business runs in dozens of currencies. Sokin was built for that with regulated, multi-currency payments and foreign exchange for organisations that operate internationally. We’re proud to be the platform behind the business payments and FX of one of the most iconic teams in football. Sokin’s platform serves businesses in more than 170 countries. We’re thrilled to be partners for the season ahead. An organisation as sophisticated as Chelsea doesn’t leave its finances to chance.”

About Sokin

Sokin is the financial layer global business runs on. Businesses can transact, convert and hold money in 70+ currencies across 170+ countries. Some businesses use Sokin to manage global finance in-house. Others build it into their products to power financial experiences for their customers. Businesses move more than $9 billion a year on licenses Sokin holds in 36+ countries and infrastructure Sokin owns. Founded in 2019, Sokin has raised over $100 million from investors including Morgan Stanley Expansion Capital and Prysm Capital.

About Chelsea Football Club

Chelsea Football Club is one of the biggest, most successful football clubs globally and our men’s team are reigning world champions, having won the four-yearly FIFA Club World Cup in 2025. Our women’s team, Chelsea Women, are also multiple trophy winners.

Founded in 1905, Chelsea is London’s most central football club, based at the iconic 40,000-capacity Stamford Bridge stadium. Nicknamed the Blues, the club lifted the Champions League for the first time in 2012 and domestically has won the Premier League five times, the FA Cup eight times, the Football League Cup five times and the Football League Championship once, in 1955.

The Chelsea Women’s team have enjoyed a huge amount of success and in 2025 won the FA Women’s Super League for a sixth consecutive year and the eighth time overall. The Women’s FA Cup has been won on six occasions. We have also captured the FA Women’s League Cup four times as well as reaching the UEFA Women’s Champions League final in 2021. In two seasons, 2020/21 and 2024/25, a domestic treble of trophies was secured.

The Chelsea Foundation boasts one of the most extensive community initiatives in sport, helping to improve the lives of children and young people all over the world.

Media Contacts:

Taina Biggs
taina.biggs@sokin.com 

Nerissa Chesterfield
nerissa.chesterfield@chelseafc.com 

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/chelsea-fc-announces-multi-year-sleeve-partnership-with-sokin-the-business-payments-and-fx-platform-302918466.html

Continue Reading

Technology

Amy Johnson Appointed President of GDIT

Published

on

By

RESTON, Va., Oct. 23, 2026 /PRNewswire/ — General Dynamics (NYSE:GD) announced today that Amy Johnson has been appointed as president of GDIT, effective November 3.

Johnson is a 27-year veteran of General Dynamics Mission Systems, where she held increasingly senior roles in engineering, engineering management and business leadership across cybersecurity, defense electronics, space and intelligence systems, most recently as vice president and general manager for Space, Cyber and Intelligence. She earned bachelor’s and master’s degrees in computer science and computer systems engineering. 

“Amy has a proven track record of leading teams to solve complex and highly technical challenges for our customers,” said Phebe Novakovic, CEO of General Dynamics. “I am confident that her dynamic leadership, operational rigor and deep commitment to our values and culture will deliver value to our customers, employees and shareholders.”

GDIT delivers digital modernization, cloud computing, artificial intelligence, cybersecurity and software development solutions to the U.S. federal government, defense, intelligence agencies and other customers. It is a business unit of General Dynamics, a global aerospace and defense company that offers a broad portfolio of products and services in business aviation; ship construction and repair; land combat vehicles, weapons systems and munitions; and technology products and services. General Dynamics employs more than 120,000 people worldwide and generated $52.6 billion in revenue in 2025. More information is available at gd.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/amy-johnson-appointed-president-of-gdit-302918411.html

SOURCE General Dynamics

Continue Reading

Technology

Yazan Al Homsi Invests US$500,000 in Toronto Drone Maker Arcanus Aerial Systems

Published

on

By

Private investment comes as Arcanus builds out Canadian manufacturing capacity for autonomous aerial systems

DUBAI, UAE, Oct. 23, 2026 /PRNewswire/ — Yazan Al Homsi, a UAE-based investor and managing partner of Catalyst Communications DMCC, has invested US$500,000 in Arcanus Aerial Systems Inc., a Toronto-headquartered developer and manufacturer of unmanned aerial systems for defence, public safety and critical infrastructure customers. Al Homsi is an investor only and holds no operational, advisory or board role with the company. Other terms were not disclosed.

Arcanus is a Canadian-controlled company. It currently lists more than 15 platforms across heavy-lift, intelligence, surveillance and reconnaissance (ISR), cargo, strike and counter-drone missions. According to the company, its published line-up includes:

AB 516e: a long-endurance vertical take-off fixed-wing aircraft rated for three hours of flight.AE 401: a counter-drone interceptor with a top speed of 300 km/h.AC 5250: a cargo platform with a 250 kg payload and a range of more than 2,300 km.

Alongside defence, Arcanus markets its systems for wildfire detection, search and rescue, Arctic sovereignty, border and maritime patrol, and pipeline and power line monitoring.

The company has spent 2026 assembling its domestic production base. In April, Arcanus signed a binding term sheet with Portugal-based Beyond Vision, granting it rights to manufacture, commercialize and support Beyond Vision’s unmanned aerial systems in Canada.

In June, Arcanus announced a five-year agreement appointing FeralX Systems Inc. as a non-exclusive Canadian contract manufacturer for several of its platforms.

“Canada has the engineering talent to build these systems at home, and recent years have shown how much depends on having that capacity domestically,” said Yazan Al Homsi. “What stood out to me about Arcanus was the manufacturing groundwork already in place: licensing, a production partner, and a range of aircraft that serves wildfire crews and search-and-rescue teams alongside defence customers.”

About Yazan Al Homsi

Yazan Al Homsi is a UAE-based investor and managing partner of Catalyst Communications DMCC, which he founded in Dubai in 2018. He was previously based in Vancouver, where he founded Founders Round Capital in 2017 and built a track record of investments in early-stage and small-cap companies. He earned a finance degree from McGill University in 2004 and holds the Chartered Financial Analyst designation. Before turning to investing, he spent more than a decade with PricewaterhouseCoopers in the Middle East, rising to director and focusing on transaction due diligence and valuation.

Media Contact
Catalyst Communications DMCC
catalyst-wire@protonmail.com

View original content:https://www.prnewswire.com/news-releases/yazan-al-homsi-invests-us500-000-in-toronto-drone-maker-arcanus-aerial-systems-302918414.html

SOURCE Yazan Al Homsi

Continue Reading

Trending